Teads Holding Co. (TEAD) Spending and interest coverage
- R&D / revenue · 12 months: Value 3.14%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.93%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 3.14% | Research and development expense / revenue. Period ending 2026-06-30. $38.33M ÷ $1.22B × 100 ≈ 3.14% |
| Stock-based compensation / revenue · 12 months | 0.93% | Share-based compensation / revenue. Period ending 2026-06-30. $11.41M ÷ $1.22B × 100 ≈ 0.93% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 38.33M USD | Research and Development Expense |
| Revenue | 1.22B USD | |
| Stock-based compensation | 11.41M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -389.78M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $38.33M | $1.22B | $11.41M | $-389.78M | (m) | 3.14% | 0.93% | (m) | (m) |
| 2026-03-31 | $40.26M | $1.28B | $12.91M | $-376.39M | (m) | 3.14% | 1.01% | (m) | (m) |
| 2025-12-31 | $43.55M | $1.30B | $13.71M | $-399.02M | (m) | 3.35% | 1.05% | (m) | (m) |
| 2025-09-30 | $47.51M | $1.18B | $14.35M | $-50.44M | (m) | 4.02% | 1.21% | (m) | (m) |
| 2025-06-30 | $45.82M | $1.09B | $14.76M | $-47.11M | (m) | 4.21% | 1.36% | (m) | (m) |
| 2025-03-31 | $41.87M | $959.27M | $15.47M | $-50.48M | (m) | 4.36% | 1.61% | (m) | (m) |
| 2024-12-31 | $37.08M | $889.88M | $15.46M | $-12.64M | (m) | 4.17% | 1.74% | (m) | (m) |
| 2024-09-30 | $36.02M | $903.52M | $14.47M | $-9.46M | (m) | 3.99% | 1.60% | (m) | (m) |
| 2024-06-30 | $35.64M | $909.36M | $13.47M | $-3.89M | $3.93M | 3.92% | 1.48% | -0.99× | Reported |
| 2024-03-31 | $36.28M | $921.01M | $12.46M | $-5.93M | $4.46M | 3.94% | 1.35% | -1.33× | Reported |
| 2023-12-31 | $36.40M | $935.82M | $12.14M | $-8.64M | $5.39M | 3.89% | 1.30% | -1.60× | Reported |
| 2023-09-30 | $37.49M | $945.55M | $12.02M | $-18.02M | $6.30M | 3.97% | 1.27% | -2.86× | Reported |
| 2023-06-30 | $38.73M | $944.56M | $11.68M | $-27.71M | $6.77M | 4.10% | 1.24% | -4.09× | Reported |
| 2023-03-31 | $39.20M | $969.64M | $11.54M | $-22.93M | $7.62M | 4.04% | 1.19% | -3.01× | Reported |
| 2022-12-31 | $40.32M | $992.08M | $11.66M | $-13.55M | $7.63M | 4.06% | 1.18% | -1.78× | Reported |
| 2022-09-30 | $42.47M | $1.02B | $13.71M | $-841.00K | $7.70M | 4.15% | 1.34% | -0.11× | Reported |
| 2022-06-30 | $43.21M | $1.05B | $29.45M | $-184.00K | $7.43M | 4.13% | 2.82% | -0.02× | Reported |
| 2022-03-31 | $41.17M | $1.04B | $27.55M | $19.85M | $5.67M | 3.95% | 2.64% | 3.50× | Reported |
| 2021-12-31 | $39.17M | $1.02B | $26.31M | $34.56M | $3.96M | 3.86% | 2.59% | 8.72× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $28.96M | $767.14M | $3.59M | $10.18M | $832.00K | 3.78% | 0.47% | 12.23× | Reported |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $26.39M | $687.33M | $3.88M | $-14.59M | $601.00K | 3.84% | 0.56% | -24.27× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Professional Diversity Network, Inc. (IPDN) | United States | $0.060B | |
| PodcastOne, Inc. (PODC) | United States | $0.068B | -42.98 |
| Cardlytics, Inc. (CDLX) | United States | $0.020B | -0.24 |
| INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) | United States | $0.016B | -4.22 |
| Global Interactive Technologies, Inc. (GITS) | $0.008B | ||
| Eva Live Inc (GOAI) | United States | $0.083B | |
| TaoWeave, Inc. (TWAV) | United States | $0.006B | |
| ZW Data Action Technologies Inc. (CNET) | $0.005B | -5.46 | |
| AIRWA INC. (YYAI) | United States | $0.004B | -101.45 |
| Health Catalyst, Inc. (HCAT) | United States | $0.132B | -0.56 |